Bioinnovation Capital I LP
BioInnovation Capital · adviser of record: Bioinnovation Management LLC · 2015 vintage
Bioinnovation Capital I LP is a 2015 venture fund managed by BioInnovation Capital, with $65.6mm raised (Form D, amount sold). It reported $186mm in gross assets at year-end 2023, 2.84x its size, its highest reported value.
- Latest value held
- $186mm year-end 2023
- Peak
- $186mm year-end 2023
- Fund size
- $65.6mm Form D, amount sold
- Held vs. size
- 2.84x peak 2.84x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2023 | $186mm | 2.84x | +16% |
| 2022 | $161mm | 2.45x | -1% |
| 2021 | $162mm | 2.47x | +4% |
| 2020 | $156mm | 2.37x | +21% |
| 2019 | $129mm | 1.96x | +5% |
| 2018 | $122mm | 1.86x | -1% |
| 2017 | $124mm | 1.89x | +89% |
| 2016 | $65.6mm | 1.00x | +59% |
| 2015 | $41.3mm | 0.63x | – |
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-1499811658. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.